The DASH Diet and Insulin Sensitivity
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Lifestyle modifications, including adoption of the Dietary Approaches to Stop Hypertension (DASH) dietary pattern, weight loss in individuals who are overweight or obese, and physical activity, are effective in the prevention and treatment of hypertension. A healthy lifestyle may also have beneficial effects on metabolic abnormalities, such as insulin resistance, that are associated with high blood pressure. This review examines the independent and combined effects of the DASH diet and weight loss plus exercise on blood pressure and insulin sensitivity, with a focus on recently published results from the ENCORE study. Our data suggest that the DASH eating plan alone lowers blood pressure in overweight individuals with higher than optimal blood pressure, but significant improvements in insulin sensitivity are observed only when the DASH diet is implemented as part of a more comprehensive lifestyle modification program that includes exercise and weight loss.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×
“2 years of follow-up [17].”
Sacks, F. M., Svetkey, L. P., Vollmer, W. M., Appel, L. J., Bray, G. A., Harsha, D., Obarzanek, E., Conlin, P. R., Miller, E. R., Simons-Morton, D. G., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440101 · Cited by 5,638
Blood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
Stamler, J., Vaccaro, O., Neaton, J. D., Wentworth, D., & The Multiple Risk Factor Intervention Trial Research Group (1993) · Diabetes Care · doi:10.2337/diacare.16.2.434 · Cited by 4,063 · cited 1×
“The combination of high blood pressure and diabetes—each a powerful atherogenic risk factor—places patients in “double jeopardy” for coronary heart disease, stroke, heart failure, and chronic kidney disease, greatly increasing the risk of these adverse consequences of hypertension [5, 8–11].”
Katz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931 · cited 1×
“[48]; and also by using the Insulin Sensitivity Index (ISI0,120), a method based on dynamic glucose and insulin levels [49].”
Muniyappa, R., Lee, S., Chen, H., & Quon, M. J. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00645.2007 · Cited by 1,643 · cited 1×
“Both of these surrogate measures provide estimates of insulin sensitivity that correlate closely with glucose clamp measurements and are predictive of the onset of type 2 diabetes [50].”
Law, M. R., Wald, N. J., Morris, J. K., & Jordan, R. E. (2003) · BMJ · doi:10.1136/bmj.326.7404.1427 · Cited by 1,232
Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis
Elliott, W. J., & Meyer, P. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60108-1 · Cited by 1,016
Cited by
Medina-Remón, A., Kirwan, R., Lamuela-Raventós, R. M., & Estruch, R. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2016.1158690 · Cited by 313
Shirani, F., Salehi-Abargouei, A., & Azadbakht, L. (2013) · Nutrition · doi:10.1016/j.nut.2012.12.021 · Cited by 204
Asemi, Z., Samimi, M., Tabassi, Z., & Esmaillzadeh, A. (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2013.296 · Cited by 119
Foroozanfard, F., Rafiei, H., Samimi, M., Gilasi, H. R., Gorjizadeh, R., Heidar, Z., & Asemi, Z. (2017) · Clinical Endocrinology · doi:10.1111/cen.13333 · Cited by 75
Liu, J., Wang, L., Qian, Y., Shen, Q., Yang, M., Dong, Y., Chen, H., Yang, Z., Liu, Y., Cui, X., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac487 · Cited by 12
Metadata
- Authors
- Hinderliter, A. L., Babyak, M. A., Sherwood, A., & Blumenthal, J. A.
- Venue
- Current Hypertension Reports
- Published
- 2010-11-09
- Volume
- 13
- Issue
- 1
- Pages
- 67-73
- ISSN
- 1522-6417 (ISSN-L)
- 1534-3111
- OpenAlex
- W2060458072
- Cited by
- 74
- References
- 19
- FWCI
- 3.07
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The DASH Diet and Insulin Sensitivity. https://app.cochat.ai/papers/10.1007/s11906-010-0168-5
- The paper
- Hinderliter, A. L., Babyak, M. A., Sherwood, A., & Blumenthal, J. A. (2011). The DASH Diet and Insulin Sensitivity. Current Hypertension Reports. https://doi.org/10.1007/s11906-010-0168-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.